NCMW
MRK icon

Northern Capital Management (Washington)’s Merck MRK Stock Holding History

Northern Capital Management (Washington)’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,865
Closed -$215K – 38
2023
Q2 		$215K Buy
+1,865
New +$212K 0.16% 41
2023
Q1 		– Sell
-1,865
Closed -$207K – 42
2022
Q4 		$207K Buy
+1,865
New +$191K 0.2% 38

Other funds holding MRK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Northern Capital Management (Washington)'s MRK Position: Q3 2023 in Review

Northern Capital Management (Washington) sold out of Merck (MRK) in Q3 2023, closing a stake of 1,865 shares — an estimated $215K sold.

Northern Capital Management (Washington) first reported a position in MRK in Q4 2022 and held it in 2 quarters. The position peaked at $215K in Q2 2023. 3,214 funds tracked by Wall St. Rank hold MRK as of Q3 2023.

  • Northern Capital Management (Washington) reported no remaining Merck position as of Q3 2023 after selling out during the quarter.
  • Northern Capital Management (Washington) sold 1,865 Merck shares in Q3 2023, an estimated $215K.
  • Northern Capital Management (Washington) first reported a position in Merck in Q4 2022 and held it in 2 quarters.
  • Northern Capital Management (Washington)'s Merck position peaked at $215K in Q2 2023.
  • 3,214 funds tracked by Wall St. Rank held Merck as of Q3 2023.

Based on Northern Capital Management (Washington)'s 13F filing for Q3 2023, filed 27 Oct 2023.